Sweeteners · Diets
aspartame worsens phenylalanine control in phenylketonuria
Part of: • aspartame
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Population patterns (Observational)
How the studies fall
What the evidence shows
Strong support, on biochemistry rather than trials: aspartame is a dipeptide ester of aspartic acid and phenylalanine, so people with phenylketonuria (who cannot metabolise phenylalanine) must count or avoid it — hence the FDA-required 'phenylketonurics: contains phenylalanine' label.
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LM, Geha RS, Hertelendy Z, Koestner A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny EJ, Renwick AG, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK 2002 · Regul Toxicol Pharmacol | observational | supports | moderate | Comprehensive safety review: aspartame safe for the general population, but PKU individuals must restrict it as a phenylalanine source. |
| Opladen T et al 2025 · University of Washington, Seattle, Seattle (WA) | observational | supports | moderate | GeneReviews management chapter for PTS-related BH4 deficiency (a hyperphenylalaninemia distinct from PAH-deficiency PKU); a recommendation, not a measurement: 'Persons with PTPSD on Phe-reduced diet should either avoid products containing aspartame or calculate total intake of Phe when using such products and adapt diet components accordingly.' Review — zero weight. |
| Trefz F, de Sonneville L, Matthis P, Benninger C, Lanz-Englert B, Bickel H 1994 · Hum Genet | RCT | mixed | moderate | Randomized double-blind crossover in 48 adult PKU heterozygotes (carriers), aspartame 15 or 45 mg/kg/day vs placebo, 12 wk each: 'Plasma phenylalanine significantly increased, within the normal range for PKUH, at 1 and 3 h following the morning dose of aspartame in the group receiving the 45 mg/kg per day dose only'; no effect on cognition, EEG or urinary organic acids. Carriers, not PKU patients - off-scope for this claim. |
| Council on Scientific Affairs 1985 · JAMA | observational | supports | moderate | AMA Council on Scientific Affairs safety review, no new data: 'This report examines the safety issues related to the nutritive sweetener aspartame' and advises 'Individuals who need to control their phenylalanine intake should handle aspartame like any other source of phenylalanine.' Review/guidance — zero weight. |
| Maler V, Goetz V, Tardieu M, Khalil AE, Alili JM, Meunier P, Maillot F, Labarthe F 2023 · Orphanet J Rare Dis | observational | supports | moderate | Analysis of 401 aspartame/Phe-containing drugs marketed in France found significant (medium/high, >10 mg/day) Phe intake from about half of aspartame-containing medications, concluding PKU patients on Phe-restricted diets should avoid or ac |
| Garriga MM, Metcalfe DD 1988 · Ann Allergy | observational | supports | low | Narrative review (Ann Allergy 1988), no data of its own: aspartame 'consists of two amino acids, L-aspartic acid and L-phenylalanine', and 'The FDA requires the statement 'phenylketonurics: contains phenylalanine' on labels ... because individuals with phenylketonuria (PKU) must restrict their intake of phenylalanine.' Review, zero weight. |
| van Vliet K, Melis ES, de Blaauw P, van Dam E, Maatman RGHJ, Abeln D, van Spronsen FJ, Heiner-Fokkema MR 2020 · Nutrients | in-vitro | supports | high | LC-MS/MS of 111 soft drinks from 10 European countries (95 aspartame-containing): aspartame 30-527 mg/L and total Phe 20-332 mg/L, 'highly variable among similar soft drinks bought in different countries'. Authors advocate declaring aspartame on labels 'as some drinks may be suitable for consumption by patients with Phe-restricted diets'. Measures Phe load delivered, not patient Phe control (indirect). |
| Öncel HU et al 2026 · Journal of nutrition and metabolism | observational | supports | low | Narrative safety review of aspartame notes that phenylalanine liberated from aspartame metabolism affects brain development, and states that consumption levels should be more closely monitored in special risk groups including PKU patients. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.